the name that you just mentioned and celgene and gulliad. we thought they were cheap when they were 10 or 11 times earnings b it out performed over the past month but not over the past year or five years. if you look back at the history of this index, it doubled the total performance of the snp it has huge potential customer bases and caused a tremendous amount of money and we saw that with a hepatitis drug that came out and there was about none of them you can trade a call spread risk reversal to mitigate these options. 103 and 110 and 117 selling the july, buying the 110 call for 265 and selling the 117 call for 45 cents this is only going to cost you a little bit of a buck one of the things you can take a look and if you look at the same trade inj june. this is not a trade that's going to decay very much if ibb were to pull back, you are not going to own it until it gets down other than the buck that you spent you do get participation from about 6% or 7% from the upside here >> you put in the market that's range bound even if they are che